Successful bone marrow transplantation for life threatening xanthogranuloma disseminatum in neurofibromatosis type-1

Süreyya Savaşan, Laurie Smith, Carolyn Scheer, Roger Dansey, Esteban Abella

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

A 2-yr and 9-month-old female patient with neurofibromatosis type-1 presented with hepatomegaly, anemia, thrombocytopenia, and croupy cough and diagnosed with xanthogranuloma disseminatum (XD). She failed chemotherapy consisting of steroids, 6-mercaptopurine and methotrexate. A partial response to HLH-94 therapy that included etoposide and cyclosporine A was initially observed. However, she continued to have significant organ dysfunction without further improvement at 6 months of therapy. She then received matched unrelated donor bone marrow transplantation (BMT) following carmustine, etoposide, cytarabine and melphelan conditioning with complete resolution of symptoms. BMT is an option in therapy-resistant, life threatening XD cases.

Original languageEnglish
Pages (from-to)534-536
Number of pages3
JournalPediatric Transplantation
Volume9
Issue number4
DOIs
StatePublished - Aug 2005

Keywords

  • Bone marrow transplantation
  • Mast cells
  • Neurofibromatosis type-1
  • Xanthogranuloma disseminatum

Fingerprint

Dive into the research topics of 'Successful bone marrow transplantation for life threatening xanthogranuloma disseminatum in neurofibromatosis type-1'. Together they form a unique fingerprint.

Cite this